Orexo AB (publ) (STO: ORX)

Sweden flag Sweden · Delayed Price · Currency is SEK
15.30
-0.36 (-2.30%)
Aug 30, 2024, 5:29 PM CET
-14.24%
Market Cap 527.91M
Revenue (ttm) 615.20M
Net Income (ttm) -96.60M
Shares Out 34.50M
EPS (ttm) -2.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,603
Open 16.00
Previous Close 15.66
Day's Range 15.04 - 16.00
52-Week Range 13.32 - 23.30
Beta 0.61
Analysts n/a
Price Target n/a
Earnings Date Oct 24, 2024

About Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment ... [Read more]

Sector Healthcare
Founded 1994
Employees 116
Stock Exchange Nasdaq Stockholm
Ticker Symbol ORX
Full Company Profile

Financial Performance

News

There is no news available yet.